by Mark Curtis | May 14, 2014
. Welcome to your RM deal review for the month of April. There were two notable acquisitions this past month. NeoStem entered into an agreement to acquire California Stem Cell, while Aastrom acquired Sanofi’s regenerative medicine business. Read on to find out more....
by Mark Curtis | Apr 30, 2014
. Of all the formidable challenges that a biotechnology company will stumble upon in its quest to commercialize, perhaps there is none more frustrating than a failure to get a product reimbursed by payers. After years of navigating the gauntlet of risk that is...
by Roshan Yoganathan | Apr 17, 2014
Recently Revmedx, a pioneer in the biomaterial wound dressing field, made some waves with the commercialization of its product XStatTM . XStatTM received a lot of press because of its FDA approval for use against gunshot wounds and shrapnel-related injuries in the...
by Roshan Yoganathan | Mar 7, 2014
. I’m not sure many of you are die-hard biomaterial fans like me, but there was a shot heard around the biomaterial world when Canada’s very own Professor Michael Sefton, at the University of Toronto, proposed creating a heart in a box. He made the claim nearly ten...
by Stacey Johnson | Feb 21, 2014
. Dr. Robert Langer’s enthusiasm for the limitless promise of bioengineering is infectious. With his efforts and under his tutelage, one hopes that huge advances will be made in restoring movement to the paralyzed and curing the sick through, for example, more...
Comments